论文部分内容阅读
目的通过对217例尘肺患者的治疗观察,了解薄芝糖肽在尘肺患者治疗中的应用。方法将217例尘肺患者按诊断分成三组,各组随机分成治疗组和对照组,两组在综合治疗相同的基础上,治疗组加用薄芝糖肽8ml静脉点滴,每日一次,疗程一个月,观察应用薄芝糖肽治疗后6个月内及12个月内尘肺患者呼吸系统感染人次。结果治疗组呼吸系统感染人次较对照组明显减少(p<0.05,p<0.01)。结论薄芝糖肽能增强尘肺患者的免疫力,减少呼吸系统感染的发病次数。
Objective To observe the therapeutic observation of 217 patients with pneumoconiosis and to find out the application of it in patients with pneumoconiosis. Methods 217 patients with pneumoconiosis were divided into three groups according to the diagnosis, each group was randomly divided into treatment group and control group. On the basis of the same treatment, the treatment group was treated with 8ml intravenous bolus glycoside once a day for one course of treatment Month, observing the application of thin glycopeptide within 6 months after treatment and 12 months of pneumoconiosis patients respiratory infections. Results The respiratory tract infections in the treatment group were significantly lower than those in the control group (p <0.05, p <0.01). Conclusions BTP can enhance the immunity of pneumoconiosis patients and reduce the incidence of respiratory infections.